Alpha Lactalbumin Monoclonal Antibody(9E9)

This gene encodes alpha-lactalbumin, a principal protein of milk. Alpha-lactalbumin forms the regulatory subunit of the lactose synthase (LS) heterodimer and beta 1,4-galactosyltransferase (beta4Gal-T1) forms the catalytic component. Together, these proteins enable LS to produce lactose by transfering galactose moieties to glucose. As a monomer, alpha-lactalbumin strongly binds calcium and zinc ions and may possess bactericidal or antitumor activity. A folding variant of alpha-lactalbumin, called HAMLET, likely induces apoptosis in tumor and immature cells.

Introducing the ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9), a cutting-edge product designed to revolutionize the field of biotechnology. This meticulously crafted monoclonal antibody showcases exceptional specificity and affinity towards alpha lactalbumin, a vital protein found in milk.

The ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9) is meticulously engineered using state-of-the-art techniques, ensuring unparalleled accuracy and reliability in its performance. Its unique composition allows for precise targeting and binding to alpha lactalbumin, enabling researchers and scientists to explore its various applications in the realms of diagnostics, therapeutics, and research.

With its exceptional specificity, the ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9) offers an invaluable tool for the detection and quantification of alpha lactalbumin in diverse biological samples. Its high affinity ensures minimal cross-reactivity, guaranteeing accurate and reproducible results. This antibody's exceptional performance makes it an indispensable asset in the development of diagnostic assays, facilitating the identification and monitoring of alpha lactalbumin-related disorders.

Furthermore, the ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9) holds immense potential in therapeutic applications. Its ability to specifically target alpha lactalbumin opens doors for the development of novel treatments and therapies for lactation-related disorders, such as insufficient milk production or lactation insufficiency. By harnessing the power of this antibody, researchers can explore innovative avenues to enhance lactation and improve maternal and infant health.

In the realm of research, the ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9) serves as an invaluable tool for investigating the intricate mechanisms and functions of alpha lactalbumin. Its exceptional specificity and affinity enable researchers to delve deeper into the protein's role in various physiological processes, such as lactation, immune response modulation, and cellular signaling pathways. This antibody's versatility and reliability make it an indispensable asset for scientists seeking to unravel the complexities of alpha lactalbumin.

In conclusion, the ALPHA LACTALBUMIN MONOCLONAL ANTIBODY(9E9) represents a groundbreaking advancement in biotechnology. Its exceptional specificity, affinity, and versatility make it an indispensable tool for researchers, scientists, and clinicians alike. By harnessing the power of this antibody, we can unlock new insights into the world of alpha lactalbumin, paving the way for innovative diagnostic, therapeutic, and research applications.